Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data
Authors:
- 1 June 2017
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 34 (02) , 145-166
Abstract
Metastatic liver disease is a major cause of cancer-related morbidity and mortality. Surgical resection is considered the only curative treatment, yet only a minority is eligible. Patients who present with unresectable disease are treated with systemic agents and/or locoregional therapies. The latter include thermal ablation and catheter-based transarterial interventions. Thermal ablation is reserved for those with limited tumor burden. It is used to downstage the disease to enable curative surgical resection, as an adjunct to surgery, or in select patients it is potentially curative. Transarterial therapies are indicated in those with more diffuse disease. The goals of care are to palliate symptoms and prolong survival. The indications and supporting data for thermal ablation and transarterial interventions are reviewed, technical and tumor factors that need to be considered prior to intervention are outlined, and finally several cases are presented.Keywords
This publication has 134 references indexed in Scilit:
- Uveal melanomaCancer Treatment Reviews, 2012
- Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesBritish Journal of Cancer, 2010
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?JNCI: Journal of the National Cancer Institute, 2010
- Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional studyHPB, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?Journal of Gastrointestinal Surgery, 2008
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Imaging of liver metastases: MRICancer Imaging, 2007
- Is Liver Resection Justified for Patients With Hepatic Metastases From Breast Cancer?Annals of Surgery, 2006
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003